KIDRON NADAV sold ORMP
March 30, 2026 · Form 4 insider transaction
KIDRON NADAV sold 44,818 shares of Oramed Pharmaceuticals Inc. at $3.31 per share, a transaction worth $148.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
44,818
Price
$3.31
Total value
$148.3K
InsiderKIDRON NADAV
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 30, 2026
Filing dateMarch 31, 2026
Shares owned after3,422,243
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock, par value $0.012 per share ("Common Stock"), of the Issuer used to satisfy tax withholding obligations attributable to the vesting and settlement of Restricted Stock Units, which were valued at the closing price of the Issuer's Common Stock on the date immediately prior to the vesting date, equal to $3.31 per share.